Literature DB >> 23277592

Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications.

Fabio Efficace, Francesco Lo-Coco.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23277592      PMCID： PMC3533654          DOI： 10.3324/haematol.2012.078501

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.

Authors:  Kristel Van Steen; Desmond Curran; Jocelyn Kramer; Geert Molenberghs; Ann Van Vreckem; Andrew Bottomley; Richard Sylvester
Journal:  Stat Med       Date:  2002-12-30       Impact factor: 2.373

2.  Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group.

Authors:  F Wisløff; M Hjorth
Journal:  Br J Haematol       Date:  1997-04       Impact factor: 6.998

3.  Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma.

Authors:  Dominique Dubois; Ravinder Dhawan; Helgi van de Velde; Dixie Esseltine; Sanjay Gupta; Muriel Viala; Christine de la Loge
Journal:  J Clin Oncol       Date:  2006-01-23       Impact factor: 44.544

4.  Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.

Authors:  Barbara Deschler; Gabriele Ihorst; Uwe Platzbecker; Ulrich Germing; Eva März; Marcelo de Figuerido; Kurt Fritzsche; Peter Haas; Helmut R Salih; Aristoteles Giagounidis; Dominik Selleslag; Boris Labar; Theo de Witte; Pierre Wijermans; Michael Lübbert
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

5.  Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.

Authors:  F Efficace; A Bottomley; E F Smit; P Lianes; C Legrand; C Debruyne; F Schramel; H J Smit; R Gaafar; B Biesma; C Manegold; C Coens; G Giaccone; J Van Meerbeeck
Journal:  Ann Oncol       Date:  2006-09-12       Impact factor: 32.976

6.  Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: a Nordic Lymphoma Group Trial.

Authors:  M Jerkeman; S Kaasa; M Hjermstad; S Kvaløy; E Cavallin-Stahl
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

7.  Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.

Authors:  Fabio Efficace; Pasquale F Innominato; Georg Bjarnason; Corneel Coens; Yves Humblet; Salvatore Tumolo; Dominique Genet; Marco Tampellini; Andrew Bottomley; Carlo Garufi; Christian Focan; Sylvie Giacchetti; Francis Lévi
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

8.  Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter?

Authors:  Fabio Efficace; Claudio Cartoni; Pasquale Niscola; Andrea Tendas; Elisabetta Meloni; Laura Scaramucci; Salvatore Soldati; Gregorio Antonio Brunetti; Maria Giulia Marini; Franco Mandelli
Journal:  Eur J Haematol       Date:  2012-09-20       Impact factor: 2.997

9.  Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.

Authors:  Andrew Bottomley; Corneel Coens; Fabio Efficace; Rabab Gaafar; Christian Manegold; Sjaak Burgers; Mark Vincent; Catherine Legrand; Jan P van Meerbeeck
Journal:  J Clin Oncol       Date:  2007-12-20       Impact factor: 44.544

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186
View more
  4 in total

Review 1.  Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials.

Authors:  Armin Rashidi; Roland B Walter; Martin S Tallman; Frederick R Appelbaum; John F DiPersio
Journal:  Blood       Date:  2016-06-27       Impact factor: 22.113

2.  [The usage of comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a multicenter, prospective study].

Authors:  Q Wu; R Fu; M F Zhao; Y G Ma; H Jiang; L D Hu; Y Jing; H Liu; L R Wang; L Su; Y Q Zhang; C L Zhou; Y Zhang; H Y Ren; B Jiang; H B Zhou; L Kang; L Zhang; D B Zhou; J Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14

3.  A preliminary investigation examining patient reported outcome measures for low back pain and utilisation amongst chiropractors in Australia: facilitators and barriers to clinical implementation.

Authors:  Natalie Clohesy; Anthony Schneiders
Journal:  Chiropr Man Therap       Date:  2018-10-09

4.  Longitudinal patterns of cancer patient reported outcomes in end of life care predict survival.

Authors:  George J Stukenborg; Leslie J Blackhall; James H Harrison; Patrick M Dillon; Paul W Read
Journal:  Support Care Cancer       Date:  2015-11-16       Impact factor: 3.359
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.